Emily Johns
About
Research
Publications
2026
Characterizing amyloid and tau positron emission tomography‐based stages across the clinical continuum
Cody K, Sokołowski A, Johns E, Guerra L, Winer J, Young C, Younes K, Dumitrescu L, Archer D, Durant A, Sathe A, Koran M, Mez J, Saykin A, Toga A, Cuccaro M, Tosun D, Insel P, Johnson S, Harrison T, Hohman T, Mormino E. Characterizing amyloid and tau positron emission tomography‐based stages across the clinical continuum. Alzheimer's & Dementia 2026, 22: e71017. PMID: 41505234, PMCID: PMC12782155, DOI: 10.1002/alz.71017.Peer-Reviewed Original Research
2025
Intervention on Modifiable Lifestyle and Physiological Factors via Variational Autoencoder Reveals Changes in Functional Connectivity-Mediated Risk for Alzheimer's Disease.
Orlichenko A, Ding S, Johns E, Gu Z, Tian X, Li X, Zhao Y. Intervention on Modifiable Lifestyle and Physiological Factors via Variational Autoencoder Reveals Changes in Functional Connectivity-Mediated Risk for Alzheimer's Disease. MedRxiv 2025 PMID: 41001445, DOI: 10.1101/2025.09.16.25335925.Peer-Reviewed Original ResearchAmyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort
Younes K, Johns E, Young C, Kennedy G, Mukherjee S, Vossler H, Winer J, Cody K, Henderson V, Poston K, Betthauser T, Bevis B, Brooks W, Burns J, Coombes S, DeCarli C, DiFilippo F, Duara R, Fan A, Gibbons L, Golde T, Johnson S, Lepping R, Leverenz J, McDougall S, Rogalski E, Sanders E, Pasaye J, Sridhar J, Saykin A, Sridharan A, Swerdlow R, Trittschuh E, Vaillancourt D, Vidoni E, Wang W, Mez J, Hohman T, Tosun D, Biber S, Kukull W, Crane P, Mormino E. Amyloid PET predicts longitudinal functional and cognitive trajectories in a heterogeneous cohort. Alzheimer's & Dementia 2025, 21: e70075. PMID: 40145384, PMCID: PMC11947745, DOI: 10.1002/alz.70075.Peer-Reviewed Original Research
2024
MRI-free processing of tau PET images for early detection
Carlson M, Smith V, Johns E, Young C, Vossler H, Ward T, Harrison T, Tosun D, Hohman T, Landau S, Mormino E. MRI-free processing of tau PET images for early detection. Imaging Neuroscience 2024, 2: imag-2-00369. PMID: 40800382, PMCID: PMC12315776, DOI: 10.1162/imag_a_00369.Peer-Reviewed Original ResearchChildhood sexual abuse and lifetime depressive symptoms: the importance of type and timing of childhood emotional maltreatment
Hutson L, Dan R, Brown A, Esfand S, Ruberto V, Johns E, Null K, Ohashi K, Khan A, Du F, Teicher M, Pizzagalli D. Childhood sexual abuse and lifetime depressive symptoms: the importance of type and timing of childhood emotional maltreatment. Psychological Medicine 2024, 54: 4385-4395. PMID: 39618324, PMCID: PMC11650171, DOI: 10.1017/s003329172400268x.Peer-Reviewed Original ResearchBrain encoding during perceived control as a prospective predictor of improvement in quality of life
Dan R, Brown A, Hutson L, Belleau E, Esfand S, Ruberto V, Johns E, Null K, Du F, Pizzagalli D. Brain encoding during perceived control as a prospective predictor of improvement in quality of life. Social Cognitive And Affective Neuroscience 2024, 19: nsae075. PMID: 39420578, PMCID: PMC11556337, DOI: 10.1093/scan/nsae075.Peer-Reviewed Original ResearchFlorbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation
Johns E, Vossler H, Young C, Carlson M, Winer J, Younes K, Park J, Rathmann‐Bloch J, Smith V, Harrison T, Landau S, Henderson V, Wagner A, Sha S, Zeineh M, Zaharchuk G, Poston K, Davidzon G, Mormino E. Florbetaben amyloid PET acquisition time: Influence on Centiloids and interpretation. Alzheimer's & Dementia 2024, 20: 5299-5310. PMID: 38962867, PMCID: PMC11350032, DOI: 10.1002/alz.13893.Peer-Reviewed Original ResearchTemporal tau asymmetry spectrum influences divergent behavior and language patterns in Alzheimer‘s disease
Younes K, Smith V, Johns E, Carlson M, Winer J, He Z, Henderson V, Greicius M, Young C, Mormino E, Researchers A. Temporal tau asymmetry spectrum influences divergent behavior and language patterns in Alzheimer‘s disease. Brain Behavior And Immunity 2024, 119: 807-817. PMID: 38710339, PMCID: PMC12188992, DOI: 10.1016/j.bbi.2024.05.002.Peer-Reviewed Original Research
2023
Impact of florbetaben acquisition timing on continuous and dichotomous measures of amyloid burden: implications for real‐world amyloid PET interpretation
Johns E, Young C, Vossler H, Younes K, Trelle A, Poston K, Davidzon G, Mormino E. Impact of florbetaben acquisition timing on continuous and dichotomous measures of amyloid burden: implications for real‐world amyloid PET interpretation. Alzheimer's & Dementia 2023, 19 DOI: 10.1002/alz.080405.Peer-Reviewed Original ResearchImpact of florbetaben acquisition timing on continuous and dichotomous measures of amyloid burden: implications for real‐world amyloid PET interpretation
Johns E, Young C, Vossler H, Younes K, Trelle A, Poston K, Davidzon G, Mormino E. Impact of florbetaben acquisition timing on continuous and dichotomous measures of amyloid burden: implications for real‐world amyloid PET interpretation. Alzheimer's & Dementia 2023, 19 DOI: 10.1002/alz.082004.Peer-Reviewed Original Research
Get In Touch
Contacts
Email